HP and TGF-β, as two main factors in the fibrosis of bronchial and airway remodeling in asthmatic patients, showed significant changes in two asthma groups and the asthma AA-received group in the 8th week (p < 0.05) (HP; 2.83 ± 0.29 and 4.53 ± 0.29 mg/g, respectively, TGF-β; 228.33 ± 12.47 and 285.00 ± 10.80 pg/ml, respectively) (Figure 8). This evidence concerns the gene TGFB1 and asthma.